Henry Schein initiated with a Neutral at BTIG

BTIG initiated coverage of Henry Schein (HSIC) with a Neutral rating and no price target The firm says Henry Schein is a dental market leader both in the U.S. and Internationally. While the company’s scale is vast, the business is mature, the analyst tells investors in a research note. BTIG sees the dental market as highly competitive and considers the company’s low- to mid-single-digit growth as “modest.”